nelfinavir has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daily, JP; Fahey, JM; Greenblatt, DJ; Perloff, MD; von Moltke, LL | 1 |
| Flaherty, KT; Jiang, W; Lei, H; Mikochik, PJ; Ra, JH; Spitz, FR; Winkler, JD | 1 |
2 other study(ies) available for nelfinavir and Cancer of Colon
| Article | Year |
|---|---|
Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamates; Cell Line, Transformed; Colonic Neoplasms; Drug Resistance, Multiple; Furans; Gene Expression Regulation, Neoplastic; HIV Protease Inhibitors; Humans; Indinavir; Ivermectin; Nelfinavir; Ritonavir; Saquinavir; Sulfonamides; Tumor Cells, Cultured; Verapamil; Vinblastine | 2000 |
HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest.
Topics: Apoptosis; cdc25 Phosphatases; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Cyclin-Dependent Kinase 2; G1 Phase; HIV Protease Inhibitors; Humans; Melanoma; Nelfinavir; Phosphorylation; Proto-Oncogene Proteins c-akt; Retinoblastoma Protein; Signal Transduction | 2007 |